AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,707,000 | +22.8% | 281,679 | +6.0% | 0.01% | 0.0% |
| Q1 2020 | $3,833,000 | -32.3% | 265,832 | +57.2% | 0.01% | -20.0% |
| Q4 2019 | $5,661,000 | -15.5% | 169,132 | -47.2% | 0.01% | +42.9% |
| Q3 2019 | $6,702,000 | +387.8% | 320,084 | +385.0% | 0.01% | +133.3% |
| Q2 2019 | $1,374,000 | -89.2% | 65,999 | -92.1% | 0.00% | -94.0% |
| Q2 2016 | $12,757,000 | +762.0% | 831,093 | +798.5% | 0.05% | +614.3% |
| Q1 2016 | $1,480,000 | -13.3% | 92,500 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,707,000 | -12.0% | 92,500 | +20.8% | 0.01% | -22.2% |
| Q3 2015 | $1,940,000 | – | 76,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |